NON-SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON-SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists probe how new drug combo fights tough cancers
Disease control OngoingThis study is testing how well two drugs, atezolizumab and bevacizumab, work for people with inoperable liver cancer or non-small cell lung cancer that has spread to the liver. Researchers will measure how long it takes for the cancer to get worse after starting treatment. They w…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 02, 2026 08:57 UTC
-
New hope for seniors: major trial tests powerful combo against deadly lung cancer
Disease control OngoingThis study is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy helps older adults (aged 70-89) with advanced non-small cell lung cancer live longer. It aims to see if this combination is as effective and safe for this older age group as it has b…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Two-Pronged weapon tested against tough cancers
Disease control OngoingThis early-stage study is testing a new drug called MCLA-129, which is designed to attack cancer cells by blocking two different growth signals at once. It is for adults with advanced lung, stomach, head/neck, or other solid tumors that have stopped responding to standard treatme…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New Triple-Threat attack on tough lung cancers
Disease control OngoingThis study is testing whether combining three existing drugs—nivolumab, ipilimumab, and nintedanib—is safe and effective for people with advanced non-small cell lung cancer (NSCLC). It will enroll about 66 adults whose cancer has spread and has no curative treatment options. The …
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug trial targets resistant lung cancer
Disease control OngoingThis study is testing whether the drug lorlatinib can help control advanced lung cancer with a specific genetic change (ROS1-positive) after the first targeted treatment has stopped working. It will involve about 54 adults whose cancer has continued to grow despite prior therapy.…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat lung cancer patients
Disease control OngoingThis early-stage study is testing whether combining two existing cancer drugs—ceritinib and docetaxel—can help control advanced lung cancer that has stopped responding to standard chemotherapy. The trial aims to find the safest dose of this combination and see if it can shrink tu…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Radiation boost tested to supercharge lung cancer treatment
Disease control OngoingThis study is testing if adding targeted radiation to the standard first-line treatment (chemotherapy plus immunotherapy) helps people with advanced non-small cell lung cancer live longer. It aims to see if radiation can boost the immune system's ability to fight cancer throughou…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat lung cancer: experimental drug trial
Disease control OngoingThis study is testing an experimental drug called acasunlimab (GEN1046) for people with advanced non-small cell lung cancer that has returned or stopped responding to standard immunotherapy. Researchers want to see if the drug works better when given alone or combined with anothe…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Timing is everything: study tests new order for lung cancer drugs
Disease control OngoingThis study is testing if changing the order of two standard treatments—chemotherapy and immunotherapy—can improve results for people with advanced non-small cell lung cancer that has spread. It will compare two schedules: one where chemo is given a week before the immunotherapy, …
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New drug trial targets Tough-to-Treat lung cancer after standard therapies fail
Disease control OngoingThis study is testing an experimental drug called patritumab deruxtecan for people with advanced lung cancer that has a specific genetic change (EGFR mutation) and has worsened after trying at least two standard treatments. The main goal is to see how well the drug shrinks tumors…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Targeted attack on rare lung cancer mutations
Disease control OngoingThis study is testing a drug called dacomitinib for people with advanced non-small cell lung cancer who have specific, less common genetic mutations in their tumors. It aims to see how well the drug controls the cancer and how safe it is. About 30 participants will take the oral …
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Targeted radiation blasts spreading cancer cells in new trial
Disease control OngoingThis study is testing whether using a precise, high-dose radiation treatment on a few new or growing tumors can help people with advanced lung or breast cancer stay on their current medications longer. It aims to see if this approach can delay the cancer from getting worse. The t…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC